Last reviewed · How we verify
ATF-Fresenius S
ATF-Fresenius S is a drug that works by modulating the immune system.
ATF-Fresenius S is a drug that works by modulating the immune system. Used for Rheumatoid Arthritis.
At a glance
| Generic name | ATF-Fresenius S |
|---|---|
| Sponsor | Astellas Pharma China, Inc. |
| Drug class | Immune modulator |
| Target | Unknown |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
ATF-Fresenius S is a drug that modulates the immune system by targeting a specific pathway. This allows it to potentially treat various conditions by reducing inflammation and modulating the immune response.
Approved indications
- Rheumatoid Arthritis
Common side effects
- Nausea
- Headache
- Fatigue
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |